Overview

• Nageswara Rao Koneti of Rainbow Children’s Heart Institute in Hyderabad received the US patent for his KONAR-MF occluder on June 5, 2025.
• The multifunctional implant is designed to close septal defects in both children and adults with a single adaptable device.
• It can treat perimembranous and muscular ventricular septal defects, residual post-surgical defects, coronary arteriovenous fistulas and paravalvular leaks.
• Koneti called the patent a moment of pride for Indian science that demonstrates domestic innovations can meet global standards.
• The US patent paves the way for potential international deployment of the KONAR-MF occluder.